M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Intrinsic Value

The intrinsic value of one MDB stock under the Base Case scenario is 0.096 PLN. Compared to the current market price of 0.377 PLN, Medicofarma Biotech SA is Overvalued by 75%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M
Base Case Scenario

Valuation Backtest
Medicofarma Biotech SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for MDB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about MDB?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Medicofarma Biotech SA

Provide an overview of the primary business activities
of Medicofarma Biotech SA.

What unique competitive advantages
does Medicofarma Biotech SA hold over its rivals?

What risks and challenges
does Medicofarma Biotech SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medicofarma Biotech SA.

Provide P/S
for Medicofarma Biotech SA.

Provide P/E
for Medicofarma Biotech SA.

Provide P/OCF
for Medicofarma Biotech SA.

Provide P/FCFE
for Medicofarma Biotech SA.

Provide P/B
for Medicofarma Biotech SA.

Provide EV/S
for Medicofarma Biotech SA.

Provide EV/GP
for Medicofarma Biotech SA.

Provide EV/EBITDA
for Medicofarma Biotech SA.

Provide EV/EBIT
for Medicofarma Biotech SA.

Provide EV/OCF
for Medicofarma Biotech SA.

Provide EV/FCFF
for Medicofarma Biotech SA.

Provide EV/IC
for Medicofarma Biotech SA.

Compare the intrinsic valuations
of Medicofarma Biotech SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medicofarma Biotech SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medicofarma Biotech SA compared to its peers.

Compare the P/E ratios
of Medicofarma Biotech SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medicofarma Biotech SA with its peers.

Analyze the financial leverage
of Medicofarma Biotech SA compared to its main competitors.

Show all profitability ratios
for Medicofarma Biotech SA.

Provide ROE
for Medicofarma Biotech SA.

Provide ROA
for Medicofarma Biotech SA.

Provide ROIC
for Medicofarma Biotech SA.

Provide ROCE
for Medicofarma Biotech SA.

Provide Gross Margin
for Medicofarma Biotech SA.

Provide Operating Margin
for Medicofarma Biotech SA.

Provide Net Margin
for Medicofarma Biotech SA.

Provide FCF Margin
for Medicofarma Biotech SA.

Show all solvency ratios
for Medicofarma Biotech SA.

Provide D/E Ratio
for Medicofarma Biotech SA.

Provide D/A Ratio
for Medicofarma Biotech SA.

Provide Interest Coverage Ratio
for Medicofarma Biotech SA.

Provide Altman Z-Score Ratio
for Medicofarma Biotech SA.

Provide Quick Ratio
for Medicofarma Biotech SA.

Provide Current Ratio
for Medicofarma Biotech SA.

Provide Cash Ratio
for Medicofarma Biotech SA.

What is the historical Revenue growth
over the last 5 years for Medicofarma Biotech SA?

What is the historical Net Income growth
over the last 5 years for Medicofarma Biotech SA?

What is the current Free Cash Flow
of Medicofarma Biotech SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medicofarma Biotech SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medicofarma Biotech SA

Current Assets 2.9m
Cash & Short-Term Investments 59.9k
Receivables 464.8k
Other Current Assets 2.4m
Non-Current Assets 12.7m
PP&E 11.7m
Intangibles 958.2k
Other Non-Current Assets -10
Current Liabilities 3.6m
Accounts Payable 2.2m
Accrued Liabilities 1.3m
Other Current Liabilities 182k
Non-Current Liabilities 2.1m
Other Non-Current Liabilities 2.1m
Efficiency

Earnings Waterfall
Medicofarma Biotech SA

Revenue
1.4m PLN
Cost of Revenue
-195.6k PLN
Gross Profit
1.2m PLN
Operating Expenses
-2.2m PLN
Operating Income
-1m PLN
Other Expenses
-33k PLN
Net Income
-1.1m PLN

Free Cash Flow Analysis
Medicofarma Biotech SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MDB Profitability Score
Profitability Due Diligence

Medicofarma Biotech SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Negative ROIC
Negative ROE
34/100
Profitability
Score

Medicofarma Biotech SA's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

MDB Solvency Score
Solvency Due Diligence

Medicofarma Biotech SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
69/100
Solvency
Score

Medicofarma Biotech SA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDB Price Targets Summary
Medicofarma Biotech SA

There are no price targets for MDB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MDB?

Click here to dive deeper.

Dividends

Medicofarma Biotech SA
does not pay dividends
Shareholder Yield

Current shareholder yield for MDB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Medicofarma Biotech SA

Country

Poland

Industry

Life Sciences Tools & Services

Market Cap

25.6m PLN

Dividend Yield

0%

Description

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

Contact

WOJ. MAZOWIECKIE
Warsaw
Sokolowska 9/lok.U19
+48226547770
medicofarmabiotech.pl

IPO

2008-11-27

Employees

-

Officers

See Also

Discover More
What is the Intrinsic Value of one MDB stock?

The intrinsic value of one MDB stock under the Base Case scenario is 0.096 PLN.

Is MDB stock undervalued or overvalued?

Compared to the current market price of 0.377 PLN, Medicofarma Biotech SA is Overvalued by 75%.

Back to Top